Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.
Delving deep into the fundamentals of development and the frontiers of disease therapeutics, Mei Sheng Lau unravels the roles chromatin plays in gene regulation.
In the pursuit of scientific excellence, the current scholars of the A*STAR Graduate Academy hope to harness their education to contribute to Singapore’s scientific ecosystem.
Supported by A*STAR in the early days of their budding careers, scholars recount the experiences that opened the doors to bigger successes from academia to public service.
Honored with the President’s Science and Technology Awards, A*STAR researchers are shaping Singapore’s scientific landscape. Here, we spotlight three researchers who have pushed the boundaries in foundational biomedical research, translational engineering efforts and cross-cutting collaborations.
According to A*STAR Deputy Chief Executive (Research) Andy Hor, research excellence can be sustained by empowering scientific talent and working synergistically towards the bigger picture.
From music streaming technology to COVID-19 tests, A*STAR Assistant Chief Executive (Enterprise) Sze Wee Tan details how the agency is bringing their innovations out of the lab and into the real world.
Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.